![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/mozart-therapeutics-doses-first-cohort-of-participants-in-phase-1ab-clinical-trial-of-mtx101-in-development-for-treatment-of-autoimmune-diseases-302173782.html
https://www.prnewswire.com/news-releases/mozart-therapeutics-raises-25-million-in-expanded-series-a-financing-to-support-clinical-development-of-first-in-class-cd8-treg-modulators-for-the-treatment-of-autoimmune-diseases-301844098.html